case_images: PMC8520926_01
case_images: Representative images of the thoracic CT scans. Chest computed tomograms showing multifocal bilateral ground glass opacities with patchy consolidations, prominent in the peripheral distribution on day 4 after symptom onset.
case_images: fmed-08-715519-g0001.jpg
case_images: PMC8520926_01_fmed-08-715519-g0001.jpg
case_images: F1
case_images: Chest computed tomography (CT) showed multifocal bilateral ground glass opacities (GGO) with patchy consolidations, prominent in the peripheral distribution and predilected to the posterior and lower lobes (Figure 1).
case_images: Cycle threshold value of SARS-CoV-2. Blue: Nasopharyngeal swab. Red: Sputum.
case_images: fmed-08-715519-g0002.jpg
case_images: PMC8520926_01_fmed-08-715519-g0002.jpg
case_images: F2
case_images: Day 5. During this period, the patient's vital signs remained stable and SARS-CoV-2 viral copy number in NP samples continued to decrease (Figure 2).
case_images: mNGS detection and anti HHV-1 therapy. Acyclovir: 0.5 g intravenous every 8 h from Day 19 to Day 35.
case_images: fmed-08-715519-g0003.jpg
case_images: PMC8520926_01_fmed-08-715519-g0003.jpg
case_images: F3
case_images: HHV-1 in sputum increased to 81,098 reads per million (RPM). HHV-1 was also detected in blood (44 RPM), NP (89,833 RPM), lung lavage (8 RPM) and stomach fluid (46 RPM), suggesting a latent reactivation of HHV-1 (Figure 3).